Related Articles
Potential repositioning of GV1001 as a therapeutic agent for testosterone‑induced benign prostatic hyperplasia
Angiogenic systemic response to the hypoxic microenvironment in prostate tumorigenesis: A pilot study
Voltage‑gated sodium channels were differentially expressed in human normal prostate, benign prostatic hyperplasia and prostate cancer cells
Inhibitory effect of rape pollen supercritical CO2 fluid extract against testosterone‑induced benign prostatic hyperplasia in rats
α‑spinasterol from Melandrium firmum attenuates benign prostatic hyperplasia in a rat model